SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001867096-23-000145
Filing Date
2023-11-17
Accepted
2023-11-17 17:58:32
Documents
1
Period of Report
2023-11-17

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1700261903.html 4  
1 FORM 4 wk-form4_1700261903.xml 4 3646
  Complete submission text file 0001867096-23-000145.txt   5026
Mailing Address DURATA THERAPEUTICS, INC. 89 HEADQUARTERS PLAZA NORTH, 14TH FLOOR MORRISTOWN NJ 07960
Business Address
Shannon John Patrick Jr (Reporting) CIK: 0001553595 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40880 | Film No.: 231420250

Mailing Address 1375 WEST FULTON STREET, SUITE 1300 CHICAGO IL 60607
Business Address 1375 WEST FULTON STREET, SUITE 1300 CHICAGO IL 60607 844-445-5704
Xeris Biopharma Holdings, Inc. (Issuer) CIK: 0001867096 (see all company filings)

IRS No.: 871082097 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations